title: Temporal lobe epilepsy: a progressive disorder?
abstract: Temporal lobe epilepsy (TLE) can be a progressive disorder, potentially resulting in structural damage and a decline of cognitive abilities over time. This is particularly evident in cases that are refractory to medication. This review examines the changes that occur in refractory TLE over time and the factors associated with these changes. Imaging and histologic studies on the brains of patients with TLE reveal anatomic and metabolic changes associated with continued seizures. These changes can impair cognitive and behavioral function. Seizure control may help minimize or prevent these changes.
authors.affiliation: Department of Neurology, New York University Medical Center, New York, NY, USA.
authors.forename: Katherine
authors.initials: K
authors.lastname: Nearing
authors.forename: Deepak
authors.initials: D
authors.lastname: Madhavan
authors.forename: Orrin
authors.initials: O
authors.lastname: Devinsky
mesh_terms: D001284:Atrophy / Q000209:etiology / Q000473:pathology / Q000503:physiopathology; D003072:Cognition Disorders / Q000209:etiology / Q000473:pathology / Q000503:physiopathology; D018450:Disease Progression; D004827:Epilepsy / Q000188:drug therapy / Q000503:physiopathology / Q000517:prevention & control; D004833:Epilepsy, Temporal Lobe / Q000473:pathology* / Q000503:physiopathology* / Q000628:therapy; D005947:Glucose / Q000378:metabolism; D006801:Humans; D009410:Nerve Degeneration / Q000209:etiology / Q000473:pathology* / Q000503:physiopathology*; D019635:Neurosurgical Procedures / Q000592:standards; D013702:Temporal Lobe / Q000187:drug effects / Q000473:pathology* / Q000503:physiopathology*
chemical_list: D005947:Glucose